For in vitro diagnostic use. Others Elecsys Anti-HCV II IVD Elecsys® Anti-HCV II CPS_000442 08 837 031 190 8 837 031 190 08837031190 8837031190 08837031190 Anti-HCV G2 Elecsys cobas e 200 V2 Elecsys Anti-HCV II 07613336166970 Reagents, kits 200 tests cobas e 411/601/602 true 06 368 921 160 6 368 921 160 06368921160 6368921160 06368921160 Anti-HCV G2 Elecsys cobas e 100 Elecsys Anti-HCV II 07613336154304 Reagents, kits 100 tests cobas e 411/601/602 true 06 427 405 160 6 427 405 160 06427405160 6427405160 06427405160 Anti-HCV G2 Elecsys cobas e 200 Elecsys Anti-HCV II 07613336154311 Reagents, kits 200 tests cobas e 411/601/602 true 08 837 058 192 8 837 058 192 08837058192 8837058192 08837058192 Anti-HCV G2 Elecsys E2G 16x300 Elecsys Anti-HCV II 07613336224076 Reagents, kits 16 x 300 tests cobas e 402/801 true 06 427 405 190 6 427 405 190 06427405190 6427405190 06427405190 Anti-HCV G2 Elecsys cobas e 200 Elecsys Anti-HCV II 04015630930296 Reagents, kits 200 tests cobas e 411/601/602 true 08 837 058 190 8 837 058 190 08837058190 8837058190 08837058190 Anti-HCV G2 Elecsys E2G 300 V2 Elecsys Anti-HCV II 07613336166994 Reagents, kits 300 tests cobas e 402/801 true 07 026 889 190 7 026 889 190 07026889190 7026889190 07026889190 Anti-HCV G2 Elecsys E2G 300 Elecsys Anti-HCV II 04015630939947 Reagents, kits 300 tests cobas e 402/801 true 03 290 379 190 3 290 379 190 03290379190 3290379190 03290379190 Anti-HCV PC Elecsys PreciControl Anti-HCV 04015630936946 Controls 16 × 1.30 mL cobas e 402/411/601/602/801 true 08 836 981 190 8 836 981 190 08836981190 8836981190 08836981190 Anti-HCV G2 Elecsys cobas e 100 V2 Elecsys Anti-HCV II 07613336166956 Reagents, kits 100 tests cobas e 411/601/602 true 06 368 921 190 6 368 921 190 06368921190 6368921190 06368921190 Anti-HCV G2 Elecsys cobas e 100 Elecsys Anti-HCV II 04015630929689 Reagents, kits 100 tests cobas e 411/601/602 true 08 837 058 162 8 837 058 162 08837058162 8837058162 08837058162 Anti-HCV G2 Elecsys E2G 16 x 300 Anti-HCV G2 Elecsys E2G 16 x 300 07613336183052 Reagents, kits 16 x 300 tests cobas pro serology solution true 08837031501 Elecsys Anti-HCV II en 2 FF00000006FBE10E FF0000000601E10E 08837031190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative detection of antibodies to hepatitis C virus (HCV) in human adult and pediatric (ages 18 months through 21 years) serum and plasma (potassium EDTA, lithium heparin, sodium heparin, and sodium citrate). Assay results, in conjunction with other laboratory results and clinical information, may be used to aid in the presumptive diagnosis of HCV infection in persons with signs and symptoms of hepatitis and in persons at risk for hepatitis C infection. The test does not determine the state of infection or associated disease.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 08837031500 Elecsys Anti-HCV II en 2 FF00000005C3DA0E FF00000004EA480E 08837031190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useThe Elecsys Anti‑HCV II assay is an in vitro diagnostic test for the qualitative detection of antibodies to hepatitis C virus (HCV) in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en ms_06368921160_USA Elecsys Anti-HCV II en 4 FF0000000227820E FF000000013A630E 06368921160 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative detection of antibodies to hepatitis C virus (HCV) in human adult and pediatric (ages 18 months through 21 years) serum and plasma (potassium EDTA, lithium heparin, sodium heparin, and sodium citrate). Assay results, in conjunction with other laboratory results and clinical information, may be used to aid in the presumptive diagnosis of HCV infection in persons with signs and symptoms of hepatitis and in persons at risk for hepatitis C infection. The test does not determine the state of infection or associated disease.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en ms_06427405160_USA Elecsys Anti-HCV II en 4 FF00000002345D0E FF000000013A6B0E 06427405160 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative detection of antibodies to hepatitis C virus (HCV) in human adult and pediatric (ages 18 months through 21 years) serum and plasma (potassium EDTA, lithium heparin, sodium heparin, and sodium citrate). Assay results, in conjunction with other laboratory results and clinical information, may be used to aid in the presumptive diagnosis of HCV infection in persons with signs and symptoms of hepatitis and in persons at risk for hepatitis C infection. The test does not determine the state of infection or associated disease.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 08837058503 Elecsys Anti-HCV II en 1 FF0000000637940E FF0000000637940E 08837058192 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useThe Elecsys Anti‑HCV II assay is an in vitro diagnostic test for the qualitative detection of antibodies to hepatitis C virus (HCV) in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 06427405500 Elecsys Anti-HCV II en 8 FF00000004B6E80E FF000000001D5B0E 06427405190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useThe Elecsys Anti‑HCV II assay is an in vitro diagnostic test for the qualitative detection of antibodies to hepatitis C virus (HCV) in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 08837058501 Elecsys Anti-HCV II en 2 FF00000006FBE20E FF00000006005C0E 08837058190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative detection of antibodies to hepatitis C virus (HCV) in human adult and pediatric (ages 18 months through 21 years) serum and plasma (potassium EDTA, lithium heparin, sodium heparin, and sodium citrate). Assay results, in conjunction with other laboratory results and clinical information, may be used to aid in the presumptive diagnosis of HCV infection in persons with signs and symptoms of hepatitis and in persons at risk for hepatitis C infection. The test does not determine the state of infection or associated disease.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 08837058500 Elecsys Anti-HCV II en 1 FF00000004E8E50E FF00000004E8E50E 08837058190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useThe Elecsys Anti‑HCV II assay is an in vitro diagnostic test for the qualitative detection of antibodies to hepatitis C virus (HCV) in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07026889500 Elecsys Anti-HCV II en 5 FF00000004B7220E FF00000001B3A90E 07026889190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useThe Elecsys Anti‑HCV II assay is an in vitro diagnostic test for the qualitative detection of antibodies to hepatitis C virus (HCV) in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07026889501 Elecsys Anti-HCV II en 2 FF0000000393660E FF0000000256F80E 07026889190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative detection of antibodies to hepatitis C virus (HCV) in human adult and pediatric (ages 18 months through 21 years) serum and plasma (potassium EDTA, lithium heparin, sodium heparin, and sodium citrate). Assay results, in conjunction with other laboratory results and clinical information, may be used to aid in the presumptive diagnosis of HCV infection in persons with signs and symptoms of hepatitis and in persons at risk for hepatitis C infection. The test does not determine the state of infection or associated disease.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07026889500 Elecsys Anti-HCV II en 4 FF00000004437F0E FF00000000E86F0E 07026889190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useThe Elecsys Anti‑HCV II assay is an in vitro diagnostic test for the qualitative detection of antibodies to hepatitis C virus (HCV) in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en ms_03290379190 PreciControl Anti-HCV en 11 FF0000000402A30E FF0000000402A30E 03290379190 618 cobas e 411 2325 cobas e 602 2497 cobas e 801 9494 cobas e 402 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use PreciControl Anti‑HCV is used for quality control of the Anti‑HCV II immunoassay on the Elecsys and cobas e immunoassay analyzers. en ms_03290379190 PreciControl Anti-HCV en 13 FF0000000578060E FF00000000E63B0E 03290379190 618 cobas e 411 2325 cobas e 602 2497 cobas e 801 9494 cobas e 402 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use PreciControl Anti‑HCV is used for quality control of the Elecsys Anti‑HCV II immunoassay on cobas e immunoassay analyzers. en 08836981500 Elecsys Anti-HCV II en 2 FF00000005BAC70E FF00000004EA2B0E 08836981190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useThe Elecsys Anti‑HCV II assay is an in vitro diagnostic test for the qualitative detection of antibodies to hepatitis C virus (HCV) in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 08836981501 Elecsys Anti-HCV II en 2 FF00000006FBE00E FF0000000601DF0E 08836981190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative detection of antibodies to hepatitis C virus (HCV) in human adult and pediatric (ages 18 months through 21 years) serum and plasma (potassium EDTA, lithium heparin, sodium heparin, and sodium citrate). Assay results, in conjunction with other laboratory results and clinical information, may be used to aid in the presumptive diagnosis of HCV infection in persons with signs and symptoms of hepatitis and in persons at risk for hepatitis C infection. The test does not determine the state of infection or associated disease.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 06368921500 Elecsys Anti-HCV II en 9 FF00000004E9E90E FF0000000017F00E 06368921190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useThe Elecsys Anti‑HCV II assay is an in vitro diagnostic test for the qualitative detection of antibodies to hepatitis C virus (HCV) in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 08837058502 Elecsys Anti-HCV II en 3 FF0000000749FA0E FF0000000636280E 08837058162 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useElecsys Anti‑HCV II is an in vitro immunoassay for the qualitative detection of antibodies to hepatitis C virus (HCV) in human serum and plasma. Elecsys Anti‑HCV II is intended to screen individual human donors, including volunteer donors of whole blood, blood components and source plasma. The assay is also intended to be used to screen organ, tissue and cell donors, when donor samples are obtained while the donor's heart is still beating. It is not intended for use on cord blood specimens.The electrochemiluminescence immunoassay “ECLIA” is intended for use with cobas pro serology solution equipped with a cobas e 801 analytical unit. en

User Profile

Select your user profile

Elecsys^® Anti-HCV II

Overview

Ordering Information

Technical Documents

Access important product documentation including relevant certificates and other resources.

Compatible Instruments

Related products

Contact us